| 20 | 1/1 | 返回列表 |
| 查看: 592 | 回復(fù): 19 | |||
| 【有獎交流】積極回復(fù)本帖子,參與交流,就有機會分得作者 wtxlcy 的 32 個金幣 ,回帖就立即獲得 1 個金幣,每人有 1 次機會 | |||
[交流]
哈佛大學(xué)醫(yī)學(xué)院/波士頓兒童醫(yī)院Ye Sun老師課題組誠聘博后
|
|||
|
Postdoctoral Position at Harvard Medical School Job Title: Postdoctoral Fellow Status: Regular Full Time Benefits Eligible: Yes Laboratory/Department: The laboratory of Dr. Ye Sun is in the Ophthalmology Department at Harvard Medical School and Boston Children's Hospital. The research interests in the Sun Lab focus on the molecular mechanisms during the progression of eye disorders, especially the role of immune-vascular interaction and neuroinflammation in retinal angiogenesis and degeneration in vascular eye diseases. https://immunologyphd.hms.harvard.edu/people/ye-sun Position Description: The NIH-funded postdoctoral position is immediately available and offers the exciting opportunity to learn cutting-edge technologies and be on the forefront of medical research. The position will involve the use of disease mouse models, Cre/loxP system, immunohistochemistry, western blotting, qRT-PCR, cloning, AAV preparation, flow cytometer, two-photon microscopy, confocal microscopy and other living imaging techniques. In addition, there will be many opportunities to collaborate with various labs both within Harvard Medical School and Boston Children's Hospital, and the surrounding hospitals and research institutions. The position provides incredible opportunities to work on a translational disease model in the world renown Longwood Medical Area. Supported by a community of talented clinicians and researchers in the world's largest pediatric research center, the position will help hone research skills, critical and interdisciplinary thinking, and scientific writing. Education: Candidates should have a PhD in immunology, molecular biology, biochemistry, genetics, or biomedical sciences and previous experience with microscopy and image analysis in a biological context, i.e. immunology, neurobiology, developmental biology, molecular and cellular biology, or genetics. Preference will be given to highly motivated and focused applicants with evidence of excellent communication, scientific engagement and published papers in peer-reviewed journals. Application Instructions: Applicants should submit a cover letter detailing their research experiences and interests, a CV, a potential start date, and the full contact information of three references to ye.sun@childrens.harvard.edu 發(fā)自小木蟲IOS客戶端 |
» 搶金幣啦!回帖就可以得到:
+1/180
+1/88
+1/87
+2/48
+2/44
+2/42
+1/38
+1/34
+1/25
+1/17
+1/12
+1/9
+1/9
+1/7
+1/5
+1/5
+1/2
+1/2
+1/2
+1/1
禁蟲 (文學(xué)泰斗)
|
本帖內(nèi)容被屏蔽 |




| 20 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0857 資源與環(huán)境 285分 +5 | 未名考生 2026-03-09 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 考研材料與化工,求調(diào)劑 +7 | 戲精丹丹丹 2026-03-09 | 7/350 |
|
|
[考研] 材料調(diào)劑,307分 +12 | 張泳銘1 2026-03-09 | 13/650 |
|
|
[考研] 材料工程專碩,一志愿中國礦業(yè)大學(xué),總分314,求調(diào)劑 +4 | 無懈可擊的巨人 2026-03-10 | 4/200 |
|
|
[考研] 一志愿211,0860總分286食品工程專業(yè)求調(diào)劑 +8 | 林林Winnie 2026-03-05 | 8/400 |
|
|
[考研] 歡迎211本科同學(xué),過A區(qū)國家線,A區(qū)非偏遠一本,交叉學(xué)科課題組 +23 | lisimayy 2026-03-04 | 37/1850 |
|
|
[考研] 085602化工求調(diào)劑 +7 | 董boxing 2026-03-10 | 7/350 |
|
|
[考研] 一志愿天大化工(085600)調(diào)劑總分338 +5 | 蔡大美女 2026-03-09 | 5/250 |
|
|
[考研] 0703化學(xué)調(diào)劑 +7 | 小奶蒼 2026-03-07 | 7/350 |
|
|
[考研] 310 070300化學(xué)求調(diào)劑 +4 | 撲風鈴的貓 2026-03-08 | 5/250 |
|
|
[考研] 313求調(diào)劑 +4 | Yyt楊1 2026-03-07 | 5/250 |
|
|
[考研] 0703化學(xué)求調(diào)劑 +4 | 很老實人 2026-03-09 | 4/200 |
|
|
[考研] 0856求調(diào)劑 +3 | squirtle11 2026-03-07 | 3/150 |
|
|
[考研] 085701環(huán)境工程專碩求調(diào)劑 +5 | 幼稚園大班打手 2026-03-08 | 5/250 |
|
|
[考研] 0856材料與化工290求調(diào)劑 +7 | Nebulala 2026-03-08 | 8/400 |
|
|
[考研] 085701環(huán)境工程專業(yè),初試305,均過國家A區(qū)線 +7 | 卡卡來了@ 2026-03-07 | 8/400 |
|
|
[考研] 081700學(xué)碩一志愿北京化工大學(xué)數(shù)二英一過六級有競賽求調(diào)劑 +5 | galaxary 2026-03-07 | 7/350 |
|
|
[考研] 316求調(diào)劑 +3 | 林小星發(fā)大財 2026-03-05 | 5/250 |
|
|
[考研] 334求調(diào)劑 +6 | Trying] 2026-03-05 | 8/400 |
|
|
[考研] 286 +6 | ksncj 2026-03-04 | 6/300 |
|